<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 13F
FORM 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: September 30, 2000
------------------
Check here if Amendment [ ]; Amendment Number:
--------------------------------
This Amendment (Check only one.): [ ] is a restatement.
[ ] adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Perseus, L.L.C.
------------------------------------------------
Address: The Army and Navy Club Building
------------------------------------------------
1627 I Street, N.W., Suite 610
------------------------------------------------
Washington, D.C. 20006
------------------------------------------------
Form 13F File Number: 028-05587
The institutional investment manager filing this report and the person by whom
it is signed hereby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that it is understood that all required items, statements,
schedules, lists, and tables, are considered integral parts of this form.
Person Signing this Report on Behalf of Reporting Manager:
Name: Rodd Macklin
-------------------------------------------------------
Title: Chief Financial Officer, Treasurer and Secretary
-------------------------------------------------------
Phone: (202) 452-0101
-------------------------------------------------------
Signature, Place, and Date of Signing:
<TABLE>
<S> <C> <C>
/s/ RODD MACKLIN Washington, D.C. December 8, 2000
------------------------------------ ----------------------------- ----------------------
[Signature] [City, State] [Date]
</TABLE>
Report Type (Check only one.):
[X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting
manager are reported in this report.)
[ ] 13F NOTICE. (Check here if no holdings reported are in this report,
and all holdings are reported by other reporting manager(s).)
[ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for
this reporting manager are reported in this report and a portion are
reported by other reporting manager(s).)
<PAGE> 2
FORM 13F SUMMARY PAGE
<TABLE>
<S> <C>
Report Summary:
Number of Other Included Managers: 0
----------------------
Form 13F Information Table Entry Total: 29
----------------------
Form 13F Information Table Value Total: $27,720
----------------------
(thousands)
</TABLE>
List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all
institutional investment managers with respect to which this report is filed,
other than the manager filing this report.
NONE
<PAGE> 3
FORM 13F INFORMATION TABLE
<TABLE>
<CAPTION>
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
------------------ --------------- ---------- ----------- ------------------------- ----------- ---------- ---------------------
VOTING AUTHORITY
SHRS OR SH PUT/ INVESTMENT OTHER ---------------------
NAME OF ISSUER TITLE OF CLASS CUSIP VALUE (x$) PRN AMT /PR CALL DISCRETION MANAGERS SOLE SHARED NONE
------------------ --------------- ---------- ----------- --------- ------ ------ ----------- ---------- ------ ------ -----
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Millennium
Pharmaceuticals,
Inc. Common 599902103 $1,022 7,000 SH SOLE 7,000
------------------------------------------------------------------------------------------------------------------------------------
NetObjects, Inc. Common 64114L102 $179 57,209 SH SOLE 57,209
------------------------------------------------------------------------------------------------------------------------------------
Quidel Corporation Common 74838J101 $97 22,500 SH SOLE 22,500
------------------------------------------------------------------------------------------------------------------------------------
Immunex Corp. Common 452528102 $218 5,000 SH SOLE 5,000
------------------------------------------------------------------------------------------------------------------------------------
Alkermes, Inc. Common 01642T108 $483 12,500 SH SOLE 12,500
------------------------------------------------------------------------------------------------------------------------------------
Magainin
Pharmaceuticals,
Inc. Common 559036108 $16 5,000 SH SOLE 5,000
------------------------------------------------------------------------------------------------------------------------------------
Neurocrine
Biosciences,
Inc. Common 64125C109 $1,485 33,000 SH SOLE 33,000
------------------------------------------------------------------------------------------------------------------------------------
Johnson & Johnson Common 478160104 $329 3,500 SH SOLE 3,500
------------------------------------------------------------------------------------------------------------------------------------
Genencor
International
Inc. Common 368709101 $148 5,000 SH SOLE 5,000
------------------------------------------------------------------------------------------------------------------------------------
Pfizer Inc. Common 717081103 $1,011 22,500 SH SOLE 22,500
------------------------------------------------------------------------------------------------------------------------------------
Advanced
Neuromodulation
Systems, Inc. Common 00757T101 $536 27,500 SH SOLE 27,500
------------------------------------------------------------------------------------------------------------------------------------
Enchira
Biotechnology
Corp. Common 29251Q107 $44 5,500 SH SOLE 5,500
------------------------------------------------------------------------------------------------------------------------------------
Amgen Inc. Common 031162100 $349 5,000 SH SOLE 5,000
------------------------------------------------------------------------------------------------------------------------------------
Neose
Technologies,
Inc. Common 640522108 $968 20,000 SH SOLE 20,000
------------------------------------------------------------------------------------------------------------------------------------
Alteon, Inc. Common 02144G107 $278 92,500 SH SOLE 92,500
------------------------------------------------------------------------------------------------------------------------------------
Parexel
International
Corp. Common 699462107 $85 10,000 SH SOLE 10,000
------------------------------------------------------------------------------------------------------------------------------------
McKesson
HBOC, Inc. Common 58155Q103 $458 15,000 SH SOLE 15,000
------------------------------------------------------------------------------------------------------------------------------------
Orchid
Biosciences,
Inc. Common 68571P100 $306 9,000 SH SOLE 9,000
------------------------------------------------------------------------------------------------------------------------------------
Schering
Plough Corp. Common 806605101 $233 5,000 SH SOLE 5,000
------------------------------------------------------------------------------------------------------------------------------------
Guilford
Pharmaceuticals
Inc. Common 401829106 $92 4,000 SH SOLE 4,000
------------------------------------------------------------------------------------------------------------------------------------
Microcide
Pharmaceuticals
Inc. Common 595018102 $115 8,500 SH SOLE 8,500
------------------------------------------------------------------------------------------------------------------------------------
Anesta Corp. Common 034603100 $230 10,000 SH SOLE 10,000
------------------------------------------------------------------------------------------------------------------------------------
Synaptic
Pharmaceutical
Corp. Common 87156R109 $153 21,600 SH SOLE 21,600
------------------------------------------------------------------------------------------------------------------------------------
[Repeat as necessary]
</TABLE>
<PAGE> 4
FORM 13F INFORMATION TABLE
<TABLE>
<CAPTION>
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
------------------ --------------- ---------- ----------- --------------------- ----------- ---------- ----------------------
VOTING AUTHORITY
SHRS OR SH/ PUT/ INVESTMENT OTHER ---------------------
NAME OF ISSUER TITLE OF CLASS CUSIP VALUE (x$) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE
------------------ --------------- ---------- ----------- --------- ----- ---- ----------- ---------- ------- ------ ----
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Tularik, Inc. Common 899165104 $413 12,500 SH SOLE 12,500
------------------------------------------------------------------------------------------------------------------------------------
Tripos Inc. Common 896928108 $216 7,500 SH SOLE 7,500
------------------------------------------------------------------------------------------------------------------------------------
Cor
Therapeutics
Inc. Common 217753102 $312 5,000 SH SOLE 5,000
------------------------------------------------------------------------------------------------------------------------------------
Abgenix Inc. Common 00339B107 $808 10,000 SH SOLE 10,000
------------------------------------------------------------------------------------------------------------------------------------
NPS
Pharmaceuticals
Inc. Common 62936P103 $679 12,000 SH SOLE 12,000
------------------------------------------------------------------------------------------------------------------------------------
Rosetta
Inpharmatics
Inc. Common 777777103 $16,457 589,998 SH SOLE 589,998
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
[Repeat as necessary]
</TABLE>
